Table 3 Baseline characteristics for all data and complete data by trial arm

District level

Health centers (#/%)

 District 1

7/14.9

6/13

7/19.4

6/15.8

 District 2

9/19.1

10/21.7

8/22

10/26.3

 District 3

21/44.7

20/43.5

11/30.5

12/31.6

 District 4

10/21.3

10/21.7

10/27.8

10/26.3

Cluster size (mean/range)

 District 1

7.1/1–12

24.5/1–71

7.1/1–10

23/1–58

 District 2

13.3/1–85

7.9/1–21

13.6/1–60

7.1/1–19

 District 3

13.6/1–141

6/1–29

5.8/1–32

3.8/1–10

 District 4

15/1–64

15/6–74

14.1/1–61

17.9/6–65

Health centre funding (MOH/non-MOH)

 District 1

6/1

5/1

6/1

5/1

 District 2

6/3

7/3

6/2

7/3

 District 3

13/8

10/10

7/4

7/5

 District 4

7/3

8/2

7/3

8/2

Cluster level:

# of health centres

47^a

46^a

36

38

Cluster size (mean/range)

13/1–141

12/1–74

10.1/1–60

11.4/1–58

Health centre funding (MOH/non-MOH

32/15

30/16

26/10

27/11

Patient level:

# of patients

605

548

364

434

Age in years (mean/range)

35.4/0–94

36.3/0–94

37.3/0–94

37.2/0–94

Women (#/%)

273/45.1

227/41.4

174/47.8

187/43.1

Pulmonary TB cases (#/%)

457/75.5

455/83

288/79

369/85

HIV status (#/%)

 Positive

 Negative

 Inconclusive

 Not done

 Unknown

310 (51.24)

285 (47.11)

1 (0.17)

0 (0)

9 (1.49)

284 (51.82)

254 (46.35)

0 (0)

1 (0.18)

9 (1.64)

200 (54.95)

164 (45.05)

0 (0)

0 (0)

0 (0)

225 (51.84)

201 (46.31)

0 (0)

1 (0.23)

7 (1.61)